Literature DB >> 24900622

Probing the Binding Site of Bile Acids in TGR5.

Antonio Macchiarulo1, Antimo Gioiello1, Charles Thomas2, Thijs W H Pols2, Roberto Nuti3, Cristina Ferrari1, Nicola Giacchè3, Francesca De Franco3, Mark Pruzanski4, Johan Auwerx2, Kristina Schoonjans2, Roberto Pellicciari5.   

Abstract

TGR5 is a G-protein-coupled receptor (GPCR) mediating cellular responses to bile acids (BAs). Although some efforts have been devoted to generate homology models of TGR5 and draw structure-activity relationships of BAs, none of these studies has hitherto described how BAs bind to TGR5. Here, we present an integrated computational, chemical, and biological approach that has been instrumental to determine the binding mode of BAs to TGR5. As a result, key residues have been identified that are involved in mediating the binding of BAs to the receptor. Collectively, these results provide new hints to design potent and selective TGR5 agonists.

Entities:  

Keywords:  Bile acids; GPCR; TGR5; diabetes; homology modeling; molecular docking; site-directed mutagenesis

Year:  2013        PMID: 24900622      PMCID: PMC4027510          DOI: 10.1021/ml400247k

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  30 in total

1.  A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors.

Authors:  Jean-Sebastien Surgand; Jordi Rodrigo; Esther Kellenberger; Didier Rognan
Journal:  Proteins       Date:  2006-02-01

2.  Charting the chemical space of target sites: insights into the binding modes of amine and amidine groups.

Authors:  Antonio Macchiarulo; Roberto Nuti; Gokcen Eren; Roberto Pellicciari
Journal:  J Chem Inf Model       Date:  2009-04       Impact factor: 4.956

Review 3.  Patented TGR5 modulators: a review (2006 - present).

Authors:  Antimo Gioiello; Emiliano Rosatelli; Roberto Nuti; Antonio Macchiarulo; Roberto Pellicciari
Journal:  Expert Opin Ther Pat       Date:  2012-10-06       Impact factor: 6.674

Review 4.  Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-alcoholic fatty liver disease.

Authors:  T W H Pols; J Auwerx; K Schoonjans
Journal:  Gastroenterol Clin Biol       Date:  2010-05-04

Review 5.  Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes?

Authors:  Filip K Knop
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-04-27       Impact factor: 4.310

Review 6.  TGR5 sequence variation in primary sclerosing cholangitis.

Authors:  Johannes R Hov; Verena Keitel; Erik Schrumpf; Dieter Häussinger; Tom H Karlsen
Journal:  Dig Dis       Date:  2011-06-17       Impact factor: 2.404

Review 7.  Bile acid metabolism and the pathogenesis of type 2 diabetes.

Authors:  Janne Prawitt; Sandrine Caron; Bart Staels
Journal:  Curr Diab Rep       Date:  2011-06       Impact factor: 4.810

8.  Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.

Authors:  Johannes R Hov; Verena Keitel; Jon K Laerdahl; Lina Spomer; Eva Ellinghaus; Abdou ElSharawy; Espen Melum; Kirsten M Boberg; Thomas Manke; Tobias Balschun; Christoph Schramm; Annika Bergquist; Tobias Weismüller; Daniel Gotthardt; Christian Rust; Liesbet Henckaerts; Clive M Onnie; Rinse K Weersma; Martina Sterneck; Andreas Teufel; Heiko Runz; Adolf Stiehl; Cyriel Y Ponsioen; Cisca Wijmenga; Morten H Vatn; Pieter C F Stokkers; Severine Vermeire; Christopher G Mathew; Benedicte A Lie; Ulrich Beuers; Michael P Manns; Stefan Schreiber; Erik Schrumpf; Dieter Häussinger; Andre Franke; Tom H Karlsen
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

9.  Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.

Authors:  Hiroyuki Sato; Antonio Macchiarulo; Charles Thomas; Antimo Gioiello; Mizuho Une; Alan F Hofmann; Régis Saladin; Kristina Schoonjans; Roberto Pellicciari; Johan Auwerx
Journal:  J Med Chem       Date:  2008-02-29       Impact factor: 7.446

10.  TGR5-mediated bile acid sensing controls glucose homeostasis.

Authors:  Charles Thomas; Antimo Gioiello; Lilia Noriega; Axelle Strehle; Julien Oury; Giovanni Rizzo; Antonio Macchiarulo; Hiroyasu Yamamoto; Chikage Mataki; Mark Pruzanski; Roberto Pellicciari; Johan Auwerx; Kristina Schoonjans
Journal:  Cell Metab       Date:  2009-09       Impact factor: 27.287

View more
  9 in total

1.  Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease.

Authors:  Stefano Fiorucci; Pasquale Rapacciuolo; Bianca Fiorillo; Rosalinda Roselli; Silvia Marchianò; Cristina Di Giorgio; Martina Bordoni; Rachele Bellini; Chiara Cassiano; Paolo Conflitti; Bruno Catalanotti; Vittorio Limongelli; Valentina Sepe; Michele Biagioli; Angela Zampella
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

2.  Discovery of a Potent and Orally Efficacious TGR5 Receptor Agonist.

Authors:  Sameer Agarwal; Amit Patil; Umesh Aware; Prashant Deshmukh; Brijesh Darji; Santosh Sasane; Kalapatapu V V M Sairam; Priyanka Priyadarsiny; Poonam Giri; Harilal Patel; Suresh Giri; Mukul Jain; Ranjit C Desai
Journal:  ACS Med Chem Lett       Date:  2015-11-20       Impact factor: 4.345

3.  The bile acid-sensitive ion channel (BASIC) is activated by alterations of its membrane environment.

Authors:  Axel Schmidt; Pia Lenzig; Adrienne Oslender-Bujotzek; Jana Kusch; Susana Dias Lucas; Stefan Gründer; Dominik Wiemuth
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

4.  Structural assemblies of the di- and oligomeric G-protein coupled receptor TGR5 in live cells: an MFIS-FRET and integrative modelling study.

Authors:  Annemarie Greife; Suren Felekyan; Qijun Ma; Christoph G W Gertzen; Lina Spomer; Mykola Dimura; Thomas O Peulen; Christina Wöhler; Dieter Häussinger; Holger Gohlke; Verena Keitel; Claus A M Seidel
Journal:  Sci Rep       Date:  2016-11-11       Impact factor: 4.379

5.  Identification of key amino acid residues in the hTGR5-nomilin interaction and construction of its binding model.

Authors:  Takashi Sasaki; Moeko Mita; Naho Ikari; Ayane Kuboyama; Shuzo Hashimoto; Tatsuya Kaneko; Masaji Ishiguro; Makoto Shimizu; Jun Inoue; Ryuichiro Sato
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

6.  Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1.

Authors:  Francesco Saverio Di Leva; Carmen Festa; Adriana Carino; Simona De Marino; Silvia Marchianò; Daniele Di Marino; Claudia Finamore; Maria Chiara Monti; Angela Zampella; Stefano Fiorucci; Vittorio Limongelli
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

Review 7.  Role of Takeda G protein‑coupled receptor 5 in microvascular endothelial cell dysfunction in diabetic retinopathy (Review).

Authors:  Miao Zhang; Zhenghao Dong; Wenkang Dong; Dongdong Zhou; Xiang Ren
Journal:  Exp Ther Med       Date:  2022-09-15       Impact factor: 2.751

8.  Structure-based drug design targeting the cell membrane receptor GPBAR1: exploiting the bile acid scaffold towards selective agonism.

Authors:  Francesco Saverio Di Leva; Carmen Festa; Barbara Renga; Valentina Sepe; Ettore Novellino; Stefano Fiorucci; Angela Zampella; Vittorio Limongelli
Journal:  Sci Rep       Date:  2015-11-16       Impact factor: 4.379

9.  In Silico Workflow for the Discovery of Natural Products Activating the G Protein-Coupled Bile Acid Receptor 1.

Authors:  Benjamin Kirchweger; Jadel M Kratz; Angela Ladurner; Ulrike Grienke; Thierry Langer; Verena M Dirsch; Judith M Rollinger
Journal:  Front Chem       Date:  2018-07-02       Impact factor: 5.221

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.